During the past decade, Kerckhoff-Klinik Forschungsgesellschaft mbH conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kerckhoff-Klinik Forschungsgesellschaft mbH" #1 sponsor was "Advanz Pharma" with 1 trials, followed by "CVRx, Inc." with 1 trials sponsored, "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company" with 1 trials sponsored, "Symetis SA" with 1 trials sponsored and "University Medicine Greifswald" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kerckhoff-Klinik Forschungsgesellschaft mbH" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "ENDI-Foundation, Bad Homburg, Germany" with 1 trials as a collaborator and "Krupp von Bohlen und Halbach-Foundation, Essen, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Kerckhoff-Klinik Forschungsgesellschaft mbH" are "Aortic Stenosis" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Atrial Fibrillation" (1 trials), "Cardiovascular Diseases" (1 trials) and "Diastolic Heart Failure" (1 trials). Many other conditions were trialed in "Kerckhoff-Klinik Forschungsgesellschaft mbH" in a lesser frequency.

Most popular intervention types in "Kerckhoff-Klinik Forschungsgesellschaft mbH" are "Device" (3 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Non-interventional" (1 trials), "Placebo" (1 trials), "Rheos Baroreflex Activation Therapy System" (1 trials), "Transcatheter aortic valve replacement" (1 trials) and "Vernakalant (oral)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kerckhoff-Klinik Forschungsgesellschaft mbH" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Kerckhoff-Klinik Forschungsgesellschaft mbH". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Kerckhoff-Klinik Forschungsgesellschaft mbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kerckhoff-Klinik Forschungsgesellschaft mbH, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".